Differential expression of Vegfr-2 and its soluble form in preeclampsia.
Several studies have suggested that the main features of preeclampsia (PE) are consequences of endothelial dysfunction related to excess circulating anti-angiogenic factors, most notably, soluble sVEGFR-1 (also known as sFlt-1) and soluble endoglin (sEng), as well as to decreased PlGF. Recently, sol...
Main Authors: | Carine Munaut, Sophie Lorquet, Christel Pequeux, Capucine Coulon, Jeanne Le Goarant, Frédéric Chantraine, Agnès Noël, Frédéric Goffin, Vassilis Tsatsaris, Damien Subtil, Jean-Michel Foidart |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3299790?pdf=render |
Similar Items
-
Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus
by: Ewa Robak, et al.
Published: (2003-01-01) -
Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy.
by: Edouard Lecarpentier, et al.
Published: (2013-01-01) -
Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.
by: Jeanne Sibiude, et al.
Published: (2012-01-01) -
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
by: Tania Durré, et al.
Published: (2018-12-01) -
Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
by: Yasufumi Sato, et al.
Published: (2011-05-01)